Bayer halts Xarelto trial
Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036Shire is reportedly in advanced talks to acquire Baxter's biopharma spin-off Baxalta and may announce a deal this week. - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/shire_and_baxalta_near_deal_1020698CRO hopes partnership will accelerate drugs' time to market - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/medidata_teams_with_pharm-olam_1256852Appointment boosts healthcare offering - Appointments - PharmaTimes
by George Underwood
https://www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021London-based agency begins trading today - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/method_medical_media_launches_1204334Vaccine uses T-cells to potentially attack multiple strains of the virus - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/universal_flu_vaccine_to_be_tested_1206771Humira is now the only EU biologic treatment option for children with the disease - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/humira_gets_ec_approval_for_anterior_uveitis_1205082Drug is only darunavir-based STR indicated for HIV-1 infection in adults and adolescents - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/ec_approves_janssens_symtuza_1206421- Appointments - PharmaTimes
by George Underwood
https://www.pharmatimes.com/appointments/new_general_manager_for_abbie_uk_1195687If approved by the FDA, this would mark the third indication for Keytruda in metastatic NSCLC in the United States based on OS data - News - PharmaTimes
by George Underwood
https://www.pharmatimes.com/news/fda_grants_keytruda_priority_review_1233852